Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06116786 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer

Name: A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer — clinical trial record (NCT06116786)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusActive, Not Recruiting

PhasePhase 1

SponsorJohnson & Johnson Enterprise Innovation Inc.

Started2023-11-27

View on ClinicalTrials.gov ↗

The purpose of this study is to determine a safe and tolerable dose(s) of JNJ-86974680 for further research in combination with cetrelimab and radiation therapy.

Amendment history 2 changes detected by DataLookout

2026-08-29

Enrollment closed, study ongoing

2026-08-29

Final enrollment: 67 participants (planned 126)

Trial Details

NCT Number	NCT06116786
Lead Sponsor	Johnson & Johnson Enterprise Innovation Inc.
Conditions	Carcinoma, Non-small-Cell Lung
Enrollment	67 participants
Start Date	2023-11-27
Primary Completion	2027-04-14 (estimated)
Study Completion	2029-06-07 (estimated)
Updated on ClinicalTrials.gov	2026-08-28